BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26949030)

  • 1. In vivo confocal microscopy efficacy assessment of daylight photodynamic therapy in actinic keratosis patients.
    Seyed Jafari SM; Timchik T; Hunger RE
    Br J Dermatol; 2016 Aug; 175(2):375-81. PubMed ID: 26949030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
    Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
    Jordan M; Ghoreschi K; Eberle FC
    Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of reflectance confocal microscopy for monitoring treatment of actinic keratosis and field cancerization with daylight photodynamic therapy.
    Cavalcante RBM; Valente NYS; Ferreira PS; Neto CF; Torezan L
    Eur J Dermatol; 2023 Dec; 33(6):674-679. PubMed ID: 38465549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
    Rubel DM; Spelman L; Murrell DF; See JA; Hewitt D; Foley P; Bosc C; Kerob D; Kerrouche N; Wulf HC; Shumack S
    Br J Dermatol; 2014 Nov; 171(5):1164-71. PubMed ID: 24861492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
    Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
    Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
    [No Abstract]   [Full Text] [Related]  

  • 9. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
    Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
    Spelman L; Rubel D; Murrell DF; See JA; Hewitt D; Foley P; Salmon R; Kerob D; Pascual T; Shumack S; Fernandez-Penas P
    Australas J Dermatol; 2016 Feb; 57(1):24-8. PubMed ID: 25827200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
    Fargnoli MC; Ibbotson SH; Hunger RE; Rostain G; Gaastra MTW; Eibenschutz L; Cantisani C; Venema AW; Medina S; Kerrouche N; Pérez-Garcia B
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):757-762. PubMed ID: 29136306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
    Girard C; Adamski H; Basset-Séguin N; Beaulieu P; Dreno B; Riboulet JL; Lacour JP
    Ann Dermatol Venereol; 2016 Apr; 143(4):257-63. PubMed ID: 27016200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of ablative fractional laser-assisted photodynamic therapy with short-incubation time for the treatment of facial and scalp actinic keratosis: 12-month follow-up results of a randomized, prospective, comparative trial.
    Choi SH; Kim KH; Song KH
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1598-605. PubMed ID: 25640401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
    Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
    Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
    See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L
    Australas J Dermatol; 2016 Aug; 57(3):167-74. PubMed ID: 26033230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques.
    Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T
    J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo reflectance confocal microscopy for monitoring actinic keratosis treated with 5-aminolevulinic acid photodynamic therapy.
    Tan L; Zhang Y; Huang J; Tang Z; Tong X; Gao L; Zeng J
    Skin Res Technol; 2021 Sep; 27(5):871-879. PubMed ID: 33847402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole 3-acetic acid-photodynamic therapy in the treatment of multiple actinic keratoses: A proof of concept pilot study.
    Grandi V; Baldi I; Cappugi P; Mori M; Pimpinelli N
    Photodiagnosis Photodyn Ther; 2016 Dec; 16():17-22. PubMed ID: 27565032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.